Increased urinary dopamine excretion in association with bilateral carotid body tumours - Clinical, biochemical and genetic findings

Annals of Clinical Biochemistry

Volumn 43, Issue 2, 2006, Pages 156-160

  Jeffery, J ^a   Devendra, D ^b   Farrugia, J ^a   Gardner, D ^a   Murphy, M J ^c   Williams, R ^a   Ayling, R M ^a   Wilkin, T J ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; DOPAMINE; METADRENALIN; NORADRENALIN; NORMETADRENALIN; VANILMANDELIC ACID;

ADULT; ANALYTIC METHOD; ANAMNESIS; ARTICLE; CAROTID BODY TUMOR; CASE REPORT; CHEMICAL ANALYSIS; CLINICAL FEATURE; CORRELATION ANALYSIS; DOPAMINE URINE LEVEL; FAMILY HISTORY; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; LABORATORY TEST; LITERATURE; MALE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; TUMOR VASCULARIZATION; TUMOR VOLUME; URINARY EXCRETION;

3-IODOBENZYLGUANIDINE; CAROTID BODY; CAROTID BODY TUMOR; CATECHOLAMINES; DOPAMINE; HUMANS; MALE; MIDDLE AGED; MUTATION; SUCCINATE DEHYDROGENASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644668570     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306776021517     Document Type: Article

References (19)

1. Turner M, Wilkins D, Marshall AJ. Chronic bilateral carotid body tumours causing carotid sinus hypersensitivity: abolition of symptoms by permanent cardiac pacing. Heart 2000; 84: 196
2. Reschini E, Castellani M, Gerundini P. Dopamine antagonists and catecholamine-secreting tumours. Eur J Nucl Med 1998; 25: 1590-1
3. Koch CA, Rodbard JS, Brouwers FM, Eisenhofer G, Pacak K. Hypotension in a woman with a metastatic dopamine-secreting carotid body tumour. Endocr Pract 2003; 9: 310-4
4. Strauss M, Nicholas GG, Abt AB, Harrison TS, Seaton JF. Malignant catecholamine-secreting carotid body paraganglioma. Otolaryngol Head Neck Surg 1983; 91: 315-21
5. Hirano S, Shoji K, Kojima H, Omori K. Dopamine-secreting carotid body tumour. Am J Otolaryngol 1998; 19: 412-6
6. Righini CH, Pecher M, Halini S, Magne JL, Reyt E. Malignant carotid paraganglioma. A case report. Ann Otolaryngol Chir Cervico-Faciale 2003; 120: 103-8
7. Graham PE, Smythe GA, Edwards GA, Lazarus L. Laboratory diagnosis of phaeochromocytoma: which analytes should we measure? Ann Clin Biochem 1993; 30: 129-34
8. Lucon AM, Pereira MAA, Mendonca BB, Halpern A, Wajchenbeg BL, Arap S. Phaeochromocytoma: study of 50 cases. J Urol 1997; 157: 1208-12
9. McClelland P, Yaqoob M, Bone JM, Thompson P, Roberts NB. Urinary dopamine excretion in chronic renal disease. Ann Clin Biochem 1992; 29: 646-51
10. Arzoglou PL. Improving the diagnosis of malignant phaeochromocytoma with the use of likelihood ratios. Clin Chem Enzymol Commun 1990; 3: 61-8
11. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology 1999; 53: 679-83
12. Christofides JA, Fry DE. Could your laboratory diagnose a Chemodectoma? Annals of Clinical Biochemistry Supplement 1990 - Proceedings of the Focus 90 meeting in Brighton, 14-18 May, Poster Abstract C102, p. 121
13. Grufferman S, Gillman MW, Pasternak LR, Peterson CL, Young WG. Familial carotid body tumours: case report and epidemiological review. Cancer 1980; 46: 2116-22
14. Neumann HPH, Bausch B, McWhinney CR, et al. Germ-line mutations in nonsyndromic phaeochromocytoma. N Engl J Med 2002; 346: 1459-66
15. Gimenez-Roqueplo AP, Farier J, Rustin P, et al. Mutations in SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003; 63: 5615-21
16. McCaffrey TV, Meyer FB, Michels VV, Piepgras DG, Marion MS. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg 1994; 120: 1211-6
17. Benn DE, Croxson MS, Tucker K, et al. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene 2003; 22: 1358-64
18. Badenhop RF, Jansen JC, Fagan PA, et al. The prevalence of SDHB, SDHC and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features. J Med Genet 2004; 41: e99
19. Tam V, Ng KF, Fung LM, et al. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient (sic) with dopamine secreting paragangliomas. Ann Clin Biochem 2005; 42: 73-7